Search Results - "Kamath, Nikhil"

TAKEN: A Traffic Knowledge-Based Navigation System for Connected and Autonomous Vehicles by Kamath B, Nikhil, Fernandes, Roshan, Rodrigues, Anisha P, Mahmud, Mufti, Vijaya, P, Gadekallu, Thippa Reddy, Kaiser, M Shamim

“…Connected and autonomous vehicles (CAVs) have witnessed significant attention from industries, and academia for research and developments towards the on-road…”
Get full text

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy by Kaplan, Allen, MD, Ledford, Dennis, MD, Ashby, Mark, PhD, Canvin, Janice, MD, FRCPC, Zazzali, James L., PhD, Conner, Edward, MD, Veith, Joachim, MD, Kamath, Nikhil, MD, Staubach, Petra, MD, Jakob, Thilo, MD, Stirling, Robert G., MB, FRACP, Kuna, Piotr, MD, PhD, Berger, William, MD, Maurer, Marcus, MD, Rosén, Karin, MD, PhD

“…Background Patients with chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU) often continue to experience symptoms despite receiving…”
Get full text

Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective by Mai, Tu H., Han, Lyrialle W., Hsu, Joy C., Kamath, Nikhil, Pan, Lin

“…Drug development for idiopathic pulmonary fibrosis (IPF) has been challenging due to poorly understood disease etiology, unpredictable disease progression,…”
Get full text

Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study by Raghu, Ganesh, Hamblin, Mark J, Brown, A Whitney, Golden, Jeffrey A, Ho, Lawrence A, Wijsenbeek, Marlies S, Vasakova, Martina, Pesci, Alberto, Antin-Ozerkis, Danielle E, Meyer, Keith C, Kreuter, Michael, Burgess, Tracy, Kamath, Nikhil, Donaldson, Francis, Richeldi, Luca

“…Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk distance…”
Get full text

Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS) by Szefler, Stanley J., Roberts, Graham, Rubin, Adalberto S., Zielen, Stefan, Kuna, Piotr, Alpan, Oral, Anzures‐Cabrera, Judith, Chen, Qiang, Holweg, Cécile T. J., Kaminski, Janusz, Putnam, Wendy S., Matthews, John G., Kamath, Nikhil

“…Background Lebrikizumab is a monoclonal antibody that modulates activity of interleukin‐13. The Phase 3 ACOUSTICS study assessed lebrikizumab efficacy and…”
Get full text

Cryoablation versus radiofrequency ablation for treatment of atrioventricular nodal reentrant tachycardia: Cryoablation with 6-mm-tip catheters is still less effective than radiofrequency ablation by Opel, Aaisha, MRCP, MBBS, Murray, Sam, MRCP, MBChB, Kamath, Nikhil, MRCP, MBBS, Dhinoja, Mehul, MRCP, MBBS, Abrams, Dominic, MD, MRCP, Sporton, Simon, MD, MRCP, Schilling, Richard, MD, FRCP, Earley, Mark, MD, MRCP

“…Background The treatment of choice for atrioventricular nodal reentrant tachycardia (AVNRT) is catheter ablation of the atrioventricular nodal slow pathway…”
Get full text

Type 2 Biomarkers Define a Prevalent Phenotype in Moderate-to-Severe, Uncontrolled Asthma Patients: A Pooled Analysis from Lebrikizumab All-Comers Phase 2 Trials by Korenblat, Phillip E., MD, FAAAAI, Hanania, Nicola A., MD, Corren, Jonathan, MD, Olssen, Julie K., MD, MS, Kamath, Nikhil, MD, Gray, Sarah, PhD, Martin, Nicolas, Holweg, Cecile T.J., PhD, Matthews, John G., MB, BS, MRSCP, PhD, Limb, Susan L., MD, Korom, Stephan

“…Conclusions In a pooled analysis of three trials designed to evaluate the effects of lebrikizumab treatment in moderate-to-severe uncontrolled asthma, 68% of…”
Get full text

Rapid Lung Function Improvement with Lebrikizumab in Patients with Uncontrolled Asthma by Corren, Jonathan, MD, Hanania, Nicola A., MD, Korenblat, Phillip E., MD, FAAAAI, Olssen, Julie K., MD, MS, Kamath, Nikhil, MD, Gray, Sarah, PhD, Martin, Nicolas, Holweg, Cecile T.J., PhD, Matthews, John G., MB, BS, MRSCP, PhD, Limb, Susan L., MD, Korom, Stephan

“…Methods We conducted a pooled analysis of three trials (NCT00930163/NCT01545440/NCT01545453) including 565 patients with moderate-to-severe uncontrolled asthma…”
Get full text

To the Editor–Response: Cryoablation with 6-mm-tip catheter is still less effective than radiofrequency ablation by Opel, Aaisha, MRCP, MBBS, Murray, Sam, MRCP, MBChB, Kamath, Nikhil, MRCP, MBBS, Dhinoja, Mehul, MRCP, MBBS, Abrams, Dominic, MD, MRCP, Sporton, Simon, MD, MRCP, Schilling, Richard, MD, FRCP, Earley, Mark, MD, MRCP

Get full text

Barriers to accessing essential medicines for kidney disease in low- and lower middle-income countries by Francis, Anna, Abdul Hafidz, Muhammad Iqbal, Ekrikpo, Udeme E, Chen, Titi, Wijewickrama, Eranga, Tannor, Elliot K, Nakhoul, Georges, Wong, Michelle M Y, Pereira-Kamath, Nikhil, Chanchlani, Rahul, Kalyesubula, Robert, Karam, Sabine, Kumar, Vivek, Calice-Silva, Viviane, Jha, Vivekanand

Get more information

Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial by Richeldi, Luca, Schiffman, Courtney, Behr, Juergen, Inoue, Yoshikazu, Corte, Tamera, Cottin, Vincent, Jenkins, R Gisli, Nathan, Steven D, Raghu, Ganesh, Walsh, Simon L F, Jayia, Parminderjit K, Kamath, Nikhil, Martinez, Fernando J

“…A phase II trial reported clinical benefit over 28 weeks in patients with idiopathic pulmonary fibrosis who received zinpentraxin alfa. To investigate the…”
Get full text

Evaluation of inpatient postpartum recovery using the Obstetric Quality of Recovery-10 patient-reported outcome measure: a single-center observational study by Sultan, Pervez, Kamath, Nikhil, Carvalho, Brendan, Bansal, Prannal, Elkhateb, Rania, Dougan, Scott, Whittington, Julie, Guo, Nan, El-Sayed, Yasser, Mhyre, Jill, Sharawi, Nadir

“…Few adequately validated patient-reported outcome measures are available, which can assess recovery profiles following childbirth. We aimed to determine…”
Get full text

Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 : an open-label extension study by Raghu, Ganesh, Hamblin, Mark J, Brown, A. Whitney, Golden, Jeffrey A, Ho, Lawrence A, Wijsenbeek, Marlies S, Vasakova, Ma, Pesci, Alberto, Antin-Ozerkis, Danielle E, Meyer, Keith C, Kreuter, Michael, Burgess, Tracy, Kamath, Nikhil, Donaldson, Francis, Richeldi, Luca

“…Background Recombinant human pentraxin-2 (rhPTX-2) significantly decreased decline in percent predicted forced vital capacity (FVC) and stabilized 6-min walk…”
Get full text

Dynamic resource management using gesture-based user interface by Sripradha K, Nikhil Kamath K, Nilesh Nayak H, Rustagi, Ram P

“…We propose and implement a user-convenient method for dynamically utilizing resources across varying platform devices using air gesture-based user interface…”
Get full text

Comparative Pharmacokinetics and Safety Assessment of 1st‐ and 2nd‐Generation Zinpentraxin Alfa Drug Products in Healthy Volunteers: A Randomized Crossover Study by Mai, Tu H., Yadav, Rajbharan, Arjomandi, Audrey, Jung, Christine, Meier, Monika M., Donaldson, Francis, Zhao, Rui, Ding, Han‐Ting, Hsu, Joy C., Kamath, Nikhil, Pan, Lin

“…Zinpentraxin alfa is a recombinant form of the human pentraxin‐2 that was studied in idiopathic pulmonary fibrosis (IPF). To improve the purity and yield of…”
Get full text

Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders Program by Karam, Sabine, Abdul Hafidz, Muhammad Iqbal, Calice-Silva, Viviane, Chen, Titi, Dupuis, Sophie, Ekrikpo, Udeme E., Francis, Anna, Jha, Vivekanand, Kalyesubula, Robert, Kumar, Vivek, Nakhoul, Georges, Pereira-Kamath, Nikhil, Tannor, Elliot K., Tran, Anh, Wijewickrama, Eranga, Wong, Michelle M.Y., Chanchlani, Rahul

Get full text